Lysis rates with rt-PB vary between different human emboli in a rat model of cerebral embolism

被引:3
作者
Calandre, L
Grau, M
Cabello, A
机构
[1] Univ 12 Octubre Hosp, Ctr Invest, Madrid 28041, Spain
[2] Univ 12 Octubre Hosp, Dept Pathol, Madrid 28041, Spain
[3] Univ 12 Octubre Hosp, Dept Neurol, Madrid 28041, Spain
来源
FIBRINOLYSIS & PROTEOLYSIS | 1998年 / 12卷 / 02期
关键词
D O I
10.1016/S0268-9499(98)80383-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In apparently similar conditions lysis rates of cerebral emboli treated with thrombolytic drugs are quite variable. We used this model of rat embolism with human emboli to investigate whether this was, at least partially, dependent on the characteristics of the embolus. Sixty-two male Wistar rats were embolized via the external carotid artery. Emboli obtained from peripheral vessel embolectomies of two different patients were trimmed to a standardized length and diameter. Subgroups of the 9 animals in the two emboli groups (labeled groups 1 and 2) were randomly assigned to i.v. treatment with either saline, 1 mg/kg rt-PA or 10 mg/kg rt-PA. Only cases with internal carotid artery occlusion were included. Histology of both emboli was assessed by hematoxylin and eosin and trichromic Masson stainings. Recanalization rate was assessed by means of sequential angiograms, classified by TIMI grades, performed from 30 to 120 min after embolization. Complete recanalization rate in treated animals 2 h post-embolization was 88% for group 1 and 44% for group 2 (P < 0.05 chi-square test). The difference was based on the higher rate of recanalization in cases treated with 1 mg/kg rt-PA: 8/9 cases in group 1 and 2/9 cases in group 2. Both emboli had a similar structure of fibrin with blood cells, Different human emboli of similar size and apparently similar structure can show an unequal response to thrombolytic therapy. This finding could explain some of the variation in recanalization rates in cerebral embolism.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 25 条
  • [1] TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY
    ANDERSON, JL
    KARAGOUNIS, LA
    BECKER, LC
    SORENSEN, SG
    MENLOVE, RL
    [J]. CIRCULATION, 1993, 87 (06) : 1829 - 1839
  • [2] BRAATEN JV, 1993, BLOOD, V81, P1290
  • [3] RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE
    DELZOPPO, GJ
    POECK, K
    PESSIN, MS
    WOLPERT, SM
    FURLAN, AJ
    FERBERT, A
    ALBERTS, MJ
    ZIVIN, JA
    WECHSLER, L
    BUSSE, O
    GREENLEE, R
    BRASS, L
    MOHR, JP
    FELDMANN, E
    HACKE, W
    KASE, CS
    BILLER, J
    GRESS, D
    OTIS, SM
    [J]. ANNALS OF NEUROLOGY, 1992, 32 (01) : 78 - 86
  • [4] DELZOPPO GJ, 1990, STROKE, V21, P155
  • [5] LOCAL INTRA-ARTERIAL FIBRINOLYTIC THERAPY IN ACUTE CAROTID TERRITORY STROKE - A PILOT-STUDY
    DELZOPPO, GJ
    FERBERT, A
    OTIS, S
    BRUCKMANN, H
    HACKE, W
    ZYROFF, J
    HARKER, LA
    ZEUMER, H
    [J]. STROKE, 1988, 19 (03) : 307 - 313
  • [6] DELAYED STROKE FOLLOWING CAROTID OCCLUSION
    FINKLESTEIN, S
    KLEINMAN, GM
    CUNEO, R
    BARINGER, JR
    [J]. NEUROLOGY, 1980, 30 (01) : 84 - 88
  • [7] GABRIEL DA, 1992, J BIOL CHEM, V267, P24259
  • [8] ROLE OF THE ALPHA-C DOMAINS OF FIBRIN IN CLOT FORMATION
    GORKUN, OV
    VEKLICH, YI
    MEDVED, LV
    HENSCHEN, AH
    WEISEL, JW
    [J]. BIOCHEMISTRY, 1994, 33 (22) : 6986 - 6997
  • [9] HACKE W, 1993, THROMBOLYTIC THERAPY, P153
  • [10] DIFFERENTIAL SENSITIVITY OF ERYTHROCYTE-RICH AND PLATELET-RICH ARTERIAL THROMBI TO LYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A POSSIBLE EXPLANATION FOR RESISTANCE TO CORONARY THROMBOLYSIS
    JANG, IK
    GOLD, HK
    ZISKIND, AA
    FALLON, JT
    HOLT, RE
    LEINBACH, RC
    MAY, JW
    COLLEN, D
    [J]. CIRCULATION, 1989, 79 (04) : 920 - 928